499 assets in Hepatocellular Carcinoma

Therapeutic assets addressing Hepatocellular Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lisinopril Hepatocellular Carcinoma	Northwestern University	P2	CCC (48)
Memantine Hydrochloride Hepatocellular Carcinoma	Inova Health Care Services	P2	CCC (48)
Novaferon Hepatocellular Carcinoma	M.D. Anderson Cancer Center	P1/2	CCC (48)
PCV 13 Hepatocellular Carcinoma	Mayo Clinic	P1/2	CCC (48)
Pd-L1 T-Hank Hepatocellular Carcinoma	ImmunityBio, Inc.	P2	CCC (48)
Pucotenlimab Hepatocellular Carcinoma	Sun Yat-sen University	P2	CCC (48)
Renvatinib Hepatocellular Carcinoma	First Affiliated Hospital of Guangxi Medical University	P1/2	CCC (48)
Rosiglitazone Hepatocellular Carcinoma	Dan Zandberg	P2	CCC (48)
rp2 Hepatocellular Carcinoma	Replimune, Inc.	P2	CCC (48)
Sargramostim Hepatocellular Carcinoma	Mayo Clinic	P1/2	CCC (48)
Simvastatin Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CCC (48)
Surufatinib Hepatocellular Carcinoma	Zhongnan Hospital	P2	CCC (48)
Tobemstomig Hepatocellular Carcinoma	Hoffmann-La Roche	P1/2	CCC (48)
Ucpvax Hepatocellular Carcinoma	Centre Hospitalier Universitaire de Besancon	P2	CCC (48)
Ulixertinib Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CCC (48)
vg161 Hepatocellular Carcinoma	Virogin Biotech Canada Ltd	P2	CCC (48)
Vipivotide Tetraxetan Hepatocellular Carcinoma	Melissa Lumish	P2	CCC (48)
Volrustomig Hepatocellular Carcinoma	AstraZeneca	P2	CCC (48)
Zimberelimab Hepatocellular Carcinoma	University of Texas Southwestern Medical Center	P2	CCC (48)
bc3402 Hepatocellular Carcinoma	Case Comprehensive Cancer Center	P1/2	CC (47)
Bumetanide Hepatocellular Carcinoma	Memorial Sloan Kettering Cancer Center	P1/2	CC (47)
mdx2001 Hepatocellular Carcinoma	ModeX Therapeutics, An OPKO Health Company	P1/2	CC (47)
q702 Hepatocellular Carcinoma	Qurient Co., Ltd.	P1/2	CC (47)
Tak-500 Hepatocellular Carcinoma	Takeda	P1/2	CC (47)
Lorigerlimab Hepatocellular Carcinoma	MacroGenics	P1	CC (46)
abx196 Hepatocellular Carcinoma	Abivax S.A.	P1/2	CC (45)
Bifidobacterium Bifidum Hepatocellular Carcinoma	Sun Yat-sen University	P1/2	CC (45)
Eb-G3B7-Nk Dual-Target Car-Nk Cells Hepatocellular Carcinoma	Beijing Biotech	P1/2	CC (45)
Fog-001 Hepatocellular Carcinoma	Parabilis Medicines, Inc.	P1/2	CC (45)
Gdkm-100 Hepatocellular Carcinoma	Guangdong GD Kongming Biotech LLC	P1/2	CC (45)
Gnos-Pv02 Hepatocellular Carcinoma	Geneos Therapeutics	P1/2	CC (45)
Gns 561 Hepatocellular Carcinoma	Genoscience Pharma	P1/2	CC (45)
gpc3-cart cells Hepatocellular Carcinoma	Chinese PLA General Hospital	P1/2	CC (45)
Immunoglobulin G4 [221-Proline], Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Sg001 ?4-Chain), Disulfide With Human Monoclonal Sg001 ?-Chain, Dimer Hepatocellular Carcinoma	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P1/2	CC (45)
Individualized Anti-Tumor New Antigen Ineo-Vac-R01 Hepatocellular Carcinoma	Zhejiang University	P1/2	CC (45)
Ineo-Vac-P01 Hepatocellular Carcinoma	Zhejiang University	P1/2	CC (45)
Ineo-Vac-T01 Personalized T Cell Hepatocellular Carcinoma	Zhejiang University	P1/2	CC (45)
Interleukin 18 (Recombinant Human Mutein Clone St-067) Hepatocellular Carcinoma	Simcha IL-18, Inc.	P1/2	CC (45)
Nogapendekin Alfa Inbakicept Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
pm1009 Hepatocellular Carcinoma	Biotheus Inc.	P1/2	CC (45)
Ptx-9908 Hepatocellular Carcinoma	TCM Biotech International Corp.	P1/2	CC (45)
Star0602 Hepatocellular Carcinoma	Marengo Therapeutics, Inc.	P1/2	CC (45)
Super Hi-Tcr-T Cells Hepatocellular Carcinoma	Eastern Hepatobiliary Surgery Hospital	P1/2	CC (45)
Tegavivint Hepatocellular Carcinoma	Iterion Therapeutics	P1/2	CC (45)
Tipiracil Hepatocellular Carcinoma	Parabilis Medicines, Inc.	P1/2	CC (45)
Trifluridine Hepatocellular Carcinoma	Parabilis Medicines, Inc.	P1/2	CC (45)
xnw5004 Hepatocellular Carcinoma	Evopoint Biosciences Inc.	P1/2	CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (44)
Nelitolimod Hepatocellular Carcinoma	University of California, San Diego	P1/2	CC (44)
Abbv-324 Hepatocellular Carcinoma	AbbVie	P1	CC (43)

Showing 251 to 300 of 499 assets

PreviousPage 6 of 10Next